Cargando…
Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) vaccine acceptance in employees in an integrated health system in the Midwest
Autores principales: | Smith, Hayden L., Prescher, Maura J., Sittig, Katherine R., Veach, Lisa A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495635/ https://www.ncbi.nlm.nih.gov/pubmed/36168458 http://dx.doi.org/10.1017/ash.2021.166 |
Ejemplares similares
-
Description of pathogenic bacteria in patients with respiratory symptoms associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Colombia
por: Zuluaga, Nathalia, et al.
Publicado: (2023) -
2685. Impact of Education and Clinic Site Champion on Extragenital Testing for Sexually Transmitted Infection
por: Cunningham, Victoria, et al.
Publicado: (2023) -
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in a Dog in Connecticut in February 2021
por: Lee, Dong-Hun, et al.
Publicado: (2021) -
Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection in asymptomatic vaccinated healthcare workers
por: Damiani, Verena, et al.
Publicado: (2021) -
Severity, Criticality, and Fatality of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Beta Variant
por: Abu-Raddad, Laith J, et al.
Publicado: (2021)